全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

The Possibilities of Medical Cannabis Application in Dentistry in the Era of Cannabis Legislation in Morocco, One of the World’s Largest Producers of Cannabis

DOI: 10.4236/oalib.1109832, PP. 1-14

Subject Areas: Dentistry

Keywords: Cannabis, Cannabinoids, Cannabidiol, Dentistry, Periodontitis, Dental Caries, Oral Mucositis

Full-Text   Cite this paper   Add to My Lib

Abstract

Objective: The aim of this review is to discuss the potential applications of Cannabis sativa L. and its secondary metabolites in dentistry, and the legal aspect of medical cannabis in Morocco, one of the world’s largest producers of cannabis. Methods: The data was searched through PubMed database, Scopus and Science Direct-Elsevier by several keywords in various combinations with a time period 2005-2022. Unavailable in full text, non-English, non-French data were excluded, as well as studies conducted on animals. Results: The articles were of various natures and were filtered after eliminating duplicates and reading the title, summary and full text. Of the 382 articles selected, 35 were deemed relevant. Conclusions: Although Cannabis sativa L. and its compounds have officially been approved for medical use in Morocco, more clinical investigations are needed to overcome the remaining challenges to the full adoption of medical cannabis in dentistry.

Cite this paper

Zeroual, R. and Danguir, A. (2023). The Possibilities of Medical Cannabis Application in Dentistry in the Era of Cannabis Legislation in Morocco, One of the World’s Largest Producers of Cannabis. Open Access Library Journal, 10, e9832. doi: http://dx.doi.org/10.4236/oalib.1109832.

References

[1]  Lowe, H., Toyang, N., Steele, B., Bryant, J., Ngwa, W. and Nedamat, K. (2021) The Current and Potential Application of Medicinal Cannabis Products in Dentistry. Dentistry Journal, 9, Article 106. https://doi.org/10.3390/dj9090106
[2]  Que, K., He, D., Jin, Y., Wu, L., Wang, F., Zhao, Z., et al. (2017) Expression of Cannabinoid Type 1 Receptors in Human Odontoblast Cells. Journal of Endodontics, 43, 283-288. https://doi.org/10.1016/j.joen.2016.10.004
[3]  Kozono, S., Matsuyama, T., Biwasa, K.K., Kawahara, K.I., Nakajima, Y., Yoshimoto, T., et al. (2010) Involvement of the Endocannabinoid System in Periodontal Healing. Biochemical and Biophysical Research Communications, 394, 928-933. https://doi.org/10.1016/j.bbrc.2010.03.080
[4]  Radwan, M.M., Chandra, S., Gul, S. and ElSohly, M.A. (2021) Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules, 26, Article 2774. https://doi.org/10.3390/molecules26092774
[5]  Crocq, M.A. (2020) History of Cannabis and the Endocannabinoid System. Dialogues in Clinical Neuroscience, 22, 223-238. https://doi.org/10.31887/DCNS.2020.22.3/mcrocq
[6]  Pisanti, S. and Bifulco, M. (2017) Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back. Trends in Pharmacological Sciences, 38, 195-198. https://doi.org/10.1016/j.tips.2016.12.002
[7]  Grotenhermen, F. (2009) Cannabis en médecine: Un guide pratique des applications médicales du cannabis et du THC. Sélestat.
[8]  Schwertschlag, C. (2022) Qu’est-ce que le système endocannabinoïde et comment fonctionne-t-il? Laboratorios Beemine. https://thebeeminelab.com/fr/systeme-endocannabinoide
[9]  Bellocchio, L., Inchingolo, A.D., Inchingolo, A.M., Lorusso, F., Malcangi, G., Santacroce, L., et al. (2021) Cannabinoids Drugs and Oral Health—From Recreational Side-Effects to Medicinal Purposes: A Systematic Review. International Journal of Molecular, 22, Article 8329. https://doi.org/10.3390/ijms22158329
[10]  Cooper, D.L., Stephan, R. and. Maygar, C.W. (2021) Dental Anxiety Management by Full Spectrum CBD Formulations: Dual Dosing (AM/PM) Protocol in a Real-World Setting. Clinics in Medicine, 3, Article 1038. https://doi.org/10.33597/2688-6731-V3-id1038
[11]  Grossman, S., Tan, H. and Gadiwalla, Y. (2022) Cannabis and Orofacial Pain: A Systematic Review. British Journal of Oral and Maxillofacial Surgery, 60, e677-e690. https://doi.org/10.1016/j.bjoms.2021.06.005
[12]  Nitecka-Buchta, A., Nowak-Wachol, A., Wachol, K., Walczyńska-Dragon, K., Olczyk, P., Batoryna, O., et al. (2019) Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial. Journal of Clinical Medicine, 8, Article 1886. https://doi.org/10.3390/jcm8111886
[13]  Qian, H., Peng, Y., Han, C., Li, S., Huo, N., Ding, Y., et al. (2010) Activation of Cannabinoid Receptor CB2 Regulates Osteogenic and Osteoclastogenic Gene Expression in Human Periodontal Ligament Cells. Journal of Periodontal Research, 45, 504-511. https://doi.org/10.1111/j.1600-0765.2009.01265.x
[14]  Nakajima, Y., Furuichi, Y., Biswas, K.K., Hashiguchi, T., Kawahara, K.I., Yamaji, K., et al. (2006) Endocannabinoid, Anandamide in Gingival Tissue Regulates the Periodontal Inflammation through NF-Kappab Pathway Inhibition. FEBS Letters, 580, 613-619. https://doi.org/10.1016/j.febslet.2005.12.079
[15]  Ataei, A., Rahim Rezaee, S.A., Moeintaghavi, A., Ghanbari, H. and Azizi, M. (2022) Evaluation of Cannabinoid Receptors Type 1-2 in Periodontitis Patients. Clinical and Experimental Dental Research, 8, 1040-1044. https://doi.org/10.1002/cre2.608
[16]  Stahl, V. and Vasudevan, K. (2020) Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation. Cureus, 12, e6809. https://doi.org/10.7759/cureus.6809
[17]  Beneng, K., Renton, T., Yilmaz, Z., Yiangou, Y. and Anand, P. (2010) Cannabinoid Receptor CB1-Immunoreactive Nerve Fibres in Painful and Non-Painful Human Tooth Pulp. Journal of Clinical Neuroscience, 17, 1476-1479. https://doi.org/10.1016/j.jocn.2010.04.005
[18]  Aqawi, M., Sionov, R.V., Gallily, R., Friedman, M. and Steinberg, D. (2021) Anti-Bacterial Properties of Cannabigerol toward Streptococcus mutans. Frontiers in Microbiology, 12, Article 656471. https://doi.org/10.3389/fmicb.2021.656471
[19]  Li, L., Xuan, Y., Zhu, B., Wang, X., Tian, X., Zhao, L., et al. (2022) Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 8999899. https://doi.org/10.1155/2022/8999899
[20]  Picciolo, G., Pallio, G., Altavilla, D., Vaccaro, M., Oteri, G., Irrera, N., et al. (2020) β-Caryophyllene Reduces the Inflammatory Phenotype of Periodontal Cells by Targeting CB2 Receptors. Biomedicines, 8, Article 164. https://doi.org/10.3390/biomedicines8060164
[21]  Theocharis, S., Giaginis, C., Alexandrou, P., Rodriguez, J., Tasoulas, J., Danas, E., et al. (2016) Evaluation of Cannabinoid CB1 and CB2 Receptors Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients’ Survival. Tumor Biology, 37, 3647-3656. https://doi.org/10.1007/s13277-015-4182-8
[22]  Whyte, D.A., Al-Hammadi, S., Balhaj, G., Brown, O.M., Penefsky, H.S. and Souid, A.K. (2010) Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells. Pharmacology, 85, 328-335. https://doi.org/10.1159/000312686
[23]  Pan, W. and Zhang, G. (2019) Linalool Monoterpene Exerts Potent Antitumor Effects in OECM 1 Human Oral Cancer Cells by Inducing Sub-G1 Cell Cycle Arrest, Loss of Mitochondrial Membrane Potential and Inhibition of PI3K/AKT Biochemical Pathway. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 24, 323-328.
[24]  Sachs, J., McGlade, E. and Yurgelun-Todd, D. (2015) Safety and Toxicology of Cannabinoids. Neurotherapeutics, 12, 735-746. https://doi.org/10.1007/s13311-015-0380-8
[25]  Simiyu, D.C., Jang, J.H. and Lee, O.R. (2022) Understanding Cannabis sativa L.: Current Status of Propagation, Use, Legalization, and Haploid-Inducer-Mediated Genetic Engineering. Plants, 11, Article 1236. https://doi.org/10.3390/plants11091236
[26]  Ransing, R., de la Rosa, P.A., Pereira-Sanchez, V., Handuleh, J.I.M., Jerotic, S., Gupta, A.K., et al. (2022) Current State of Cannabis Use, Policies, and Research across Sixteen Countries: Cross-Country Comparisons and International Perspectives. Trends in Psychiatry and Psychotherapy, 44, e20210263. https://doi.org/10.47626/2237-6089-2021-0263
[27]  Elhamdaoui, O., Meiouet, M., Ajlal, A., Chergui, A. and Zakariya, I. (2019) Medicinal Cannabis and Challenges of Legislation in Morocco. International Journal of Pharmacognosy, 6, 323-328.
[28]  Haddou, N.B. (2021) Publication au BORM n° 7006 de la loi n° 13-21 relative aux usages licites du cannabis. https://www.lexisma.info/2021/08/06/publication-au-borm-n-7006-de-la-loi-n-13-21-relative-aux-usages-licites-du-cannabis/
[29]  Tingman, S. (2019) Local Perceptions of Cannabis and Cannabis Laws in Morocco: Unpacking Past Laws, Moroccans’ Perceptions, and Exploring Organizational Efforts. Independent Study Project (ISP) Collection. https://digitalcollections.sit.edu/isp_collection/3080

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413